Skip to search formSkip to main content

Autologous Prostate Stem Cell Antigen-specific CAR T Cells BPX-601

Known as: Autologous PSCA-specific CAR T Cells BPX-601, BPX-601, Autologous PSCA-Specific Chimeric Antigen Receptor Engineered T Cells BPX-601 
A preparation of autologous T-lymphocytes expressing a chimeric antigen receptor (CAR) consisting of an anti-human prostate stem cell antigen (PSCA… Expand
National Institutes of Health

Related topics

Related topics

4 relations
Antigen SensitizationCytotoxic T-LymphocytesT-Cell Activationimmunopotentiation

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Functional annotation of high-quality SNP biomarkers of gastric cancer susceptibility: the Yin Yang of PSCA rs2294008.
Dear Editor, We read the recent article by Mocellin et al 1 with great interest. Their comprehensive meta-analysis nominated 11… Expand
  • figure 1
  • table 1
Is this relevant?
2015
2015
Associations of Genetic Variants in the PSCA, MUC1 and PLCE1 Genes with Stomach Cancer Susceptibility in a Chinese Population
BACKGROUND Several genetic variants including PSCA rs2294008 C>T and rs2976392 G>A, MUC1 rs4072037 T>C, and PLCE1 rs2274223 A>G… Expand
  • table 1
  • table 2
  • table 4
Is this relevant?
2015
2015
PSCA rs2294008 C > T polymorphism contributes to gastric and bladder cancer risk
BACKGROUND Previous studies suggested genetic variations in PSCA (prostate stem cell antigen) may confer the susceptibility of… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Review
2014
Review
2014
Association of a common genetic variant in prostate stem cell antigen with cancer risk
INTRODUCTION Polymorphisms in the prostate stem cell antigen (PSCA) gene have been hypothesized to increase the genetic… Expand
  • figure 1
  • figure 2
Is this relevant?
2013
2013
Human prostate stem cell antigen and HSP70 fusion protein vaccine inhibits prostate stem cell antigen-expressing tumor growth in mice.
Prostate stem cell antigen (PSCA) has been considered a potentially worthwhile target for prostate cancer therapy with its… Expand
Is this relevant?
2012
2012
A phase I/IIA study of AGS-PSCA for castration-resistant prostate cancer.
BACKGROUND This first-in-human phase I/IIA study was designed to evaluate the safety and pharmacokinetics (PKs) of AGS-PSCA a… Expand
  • table 1
  • table 2
  • figure 1
Is this relevant?
2012
2012
Genetic variations of prostate stem cell antigen (PSCA) contribute to the risk of gastric cancer for Eastern Asians: a meta-analysis based on 16792 individuals.
The associations between polymorphisms of prostate stem cell antigen (PSCA-rs2294008C>T and -rs2976392G>A) and gastric cancer (GC… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2012
2012
Association of the PSCA rs2294008 C>T polymorphism with gastric cancer risk: evidence from a meta-analysis.
BACKGROUND Multiple studies have reported associations between the PSCA rs2294008 C>T polymorphism and GC, but susceptibility has… Expand
Is this relevant?
2012
2012
Association of the PSCA rs 2294008 C > T Polymorphism with Gastric Cancer Risk : Evidence from a Meta-Analysis
GC is the fourth most common malignancy and the second leading cause of cancer associated death worldwide (Ferlay et al., 2010… Expand
  • table 1
  • table 2
  • table 3
  • figure 2
  • figure 1
Is this relevant?
2005
2005
Therapeutic potential of AGS-PSCA: A fully human monoclonal antibody to prostate stem cell antigen (PSCA) for the treatment of prostate and pancreatic cancers
4722 Background: PSCA is a 123 amino acid GPI-linked surface antigen that is expressed in approximately 80% of prostate cancers… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE